肝硬化患者急性肾损伤:急性疾病质量倡议(ADQI)与国际腹水俱乐部(ICA)联合多学科共识会议
肝硬化患者易发生急性肾损伤(AKI),与住院期间并发症和死亡率显著增加及进展为慢性肾脏病风险相关。2023年国际腹水俱乐部(ICA)与急性疾病质量倡议(ADQI)联合会议制定肝硬化和AKI患者HRS-AKI的新诊断标准,并提供分级推荐。
要点
- 肝硬化患者易发生AKI,与住院并发症和死亡率显著增加及进展为慢性肾脏病风险相关。
- HRS-AKI是晚期肝硬化伴腹水患者的一种特定AKI形式,死亡风险尤其高。
- 早期识别HRS-AKI至关重要,因内脏血管收缩剂可逆转AKI并作为肝移植的桥接。
核心结论
- 2023年ICA与ADQI联合会议制定HRS-AKI新诊断标准,并提供肝硬化AKI患者检查、管理和出院后随访的分级推荐。
研究设计与样本
- 2023年国际腹水俱乐部(ICA)与急性疾病质量倡议(ADQI)联合多学科共识会议。
主要发现
- 肝硬化患者易发生AKI,与住院并发症和死亡率显著增加及进展为慢性肾脏病风险相关。
- HRS-AKI是晚期肝硬化伴腹水患者的一种特定AKI形式,死亡风险尤其高。
- 早期识别HRS-AKI至关重要,因内脏血管收缩剂可逆转AKI并作为肝移植的桥接,肝移植是唯一治愈选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Patients with cirrhosis are prone to developing acute kidney injury (AKI), a complication associated with a markedly increased in-hospital morbidity and mortality, along with a risk of progression to chronic kidney disease. Whereas patients with cirrhosis are at increased risk of developing any phenotype of AKI, hepatorenal syndrome (HRS), a specific form of AKI (HRS-AKI) in patients with advanced cirrhosis and ascites, carries an especially high mortality risk. Early recognition of HRS-AKI is crucial since administration of splanchnic vasoconstrictors may reverse the AKI and serve as a bridge to liver transplantation, the only curative option. In 2023, a joint meeting of the International Club of Ascites (ICA) and the Acute Disease Quality Initiative (ADQI) was convened to develop new diagnostic criteria for HRS-AKI, to provide graded recommendations for the work-up, management and post-discharge follow-up of patients with cirrhosis and AKI, and to highlight priorities for further research.
引用
- Nadim MK, Kellum JA, Forni L, et al. Acute kidney injury in patients with cirrhosis: Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting. J Hepatol. 2024. PMID: 38527522. doi:10.1016/j.jhep.2024.03.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。